Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Rise Of The Chinese CRO: New Models For An Emerging Player

Apr 20 2011

• By PharmAsia News

Related Content

Pfizer Signs MOU With Wuhan To Establish First R&D Center In Midwest China; Ranks Number One In China

Nov 25 2009

Pharmaron Acquires Bridge China To Become Fully-integrated CRO

Jan 15 2010

PPD Continues High-speed Expansion In Asia With Second Acquisition Of A China-based CRO This Quarter

Nov 20 2009

San Diego's Huya Signs Six New Deals With Chinese Scientific Partners, Looks To Fast Forward Global Drug Development

Feb 14 2011

Fresh Off BMS Deal, Leading Chinese CRO WuXi PharmaTech Outlines Plan To Expand Biologics Business To Keep Pace With Big Pharma

Mar 11 2011

Despite Inflationary Headwinds, Chinese CRO WuXi PharmaTech Set To Ride Wave Of Global Outsourcing

Jan 27 2011

Covance, WuXi Abandon Plans To Create Joint Drug Testing Facility In China

Oct 02 2008

China's R&D Outsourcing Market Reaches $315 Million, Expected To Maintain High Growth Through 2016

Oct 26 2010

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window